{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:04:18Z","timestamp":1773284658838,"version":"3.50.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T00:00:00Z","timestamp":1449792000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Res Clin Oncol"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1007\/s00432-015-2090-3","type":"journal-article","created":{"date-parts":[[2015,12,11]],"date-time":"2015-12-11T12:42:25Z","timestamp":1449837745000},"page":"1509-1520","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Hepatic resection during cytoreductive surgery for primary or recurrent epithelial ovarian cancer"],"prefix":"10.1007","volume":"142","author":[{"given":"Maria Luisa","family":"Gasparri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Grandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Bolla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beat","family":"Gloor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Imboden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierluigi Benedetti","family":"Panici","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael D.","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Papadia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,11]]},"reference":[{"key":"2090_CR1","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjsurg.2007.12.012","volume":"195","author":"G Abood","year":"2008","unstructured":"Abood G, Bowen M, Potkul R, Aranha G, Shoup M (2008) Hepatic resection for recurrent metastatic ovarian cancer. Am J Surg 195:370\u2013373","journal-title":"Am J Surg"},{"key":"2090_CR2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/01.sla.0000246847.02058.1b","volume":"244","author":"R Adam","year":"2006","unstructured":"Adam R, Aloia T, Krissat J, Bralet MP, Paule B, Giacchetti S, Delvart V, Azoulay D, Bismuth H, Castaing D (2006a) Is liver resection justified for patients with hepatic metastases from breast cancer? Ann Surg 244:897\u2013907","journal-title":"Ann Surg"},{"key":"2090_CR3","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/01.sla.0000246847.02058.1b","volume":"244","author":"R Adam","year":"2006","unstructured":"Adam R, Chiche L, Aloia T, Elias D, Salmon R, Rivoire M, Jaeck D, Saric J, Le Treut YP, Belghiti J, Mantion G, Mentha G, Association Fran\u00e7aise de Chirurgie (2006b) Hepatic resection for noncolorectal nonendocrine liver metastases: analysis of 1,452 patients and development of a prognostic model. Ann Surg 244:524\u2013535","journal-title":"Ann Surg"},{"key":"2090_CR4","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jamcollsurg.2006.06.027","volume":"203","author":"GD Aletti","year":"2006","unstructured":"Aletti GD, Podratz KC, Jones MB, Cliby WA (2006) Role of rectosigmoidectomy and stripping of pelvic peritoneum in outcomes of patients with advanced ovarian cancer\u2014a preliminary report. J Am Coll Surg 203:521\u2013526","journal-title":"J Am Coll Surg"},{"issue":"1","key":"2090_CR5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.gassur.2005.04.009","volume":"10","author":"A Alseidi","year":"2006","unstructured":"Alseidi A, Helton WS, Espat NJ (2006) Does the literature support an indication for hepatic metastasectomy other than for colorectal primary? J Gastrointest Surg 10(1):99\u2013104","journal-title":"J Gastrointest Surg"},{"key":"2090_CR6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"DK Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"},{"key":"2090_CR7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1245\/ASO.2003.03.018","volume":"10","author":"RJ Bleicher","year":"2003","unstructured":"Bleicher RJ, Allegra DP, Nora DT, Wood TF, Foshag LJ, Bilchik AJ (2003) Radiofrequency ablation in 447 complex unresectable liver tumors: lessons learned. Ann Surg Oncol 10:52\u201358","journal-title":"Ann Surg Oncol"},{"issue":"2","key":"2090_CR8","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.ygyno.2004.01.041","volume":"93","author":"MO Bojalian","year":"2004","unstructured":"Bojalian MO, Machado GR, Swensen R, Reeves ME (2004) Radiofrequency ablation of liver metastasis from ovarian adenocarcinoma: case report and literature review. Gynecol Oncol 93(2):557\u2013560","journal-title":"Gynecol Oncol"},{"issue":"3","key":"2090_CR9","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","volume":"72","author":"RE Bristow","year":"1999","unstructured":"Bristow RE, Montz FJ, Lagasse LD, Leuchter RS, Karlan BY (1999) Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer. Gynecol Oncol 72(3):278\u2013287","journal-title":"Gynecol Oncol"},{"key":"2090_CR10","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.20.5.1248","volume":"20","author":"RE Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a metaanalysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"2090_CR11","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMra041842","volume":"351","author":"SA Cannistra","year":"2004","unstructured":"Cannistra SA (2004) Cancer of the ovary. N Engl J Med 351:2519\u20132529","journal-title":"N Engl J Med"},{"issue":"6","key":"2090_CR12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1525-1438.2005.00169.x","volume":"15","author":"GE Chalkiadakis","year":"2005","unstructured":"Chalkiadakis GE, Lasithiotakis KG, Petrakis I, Kourousis C, Georgoulias V (2005) Major hepatectomy and right hemicolectomy at the time of primary cytoreductive surgery for advanced ovarian cancer: report of a case. Int J Gynecol Cancer 15(6):1115\u20131119","journal-title":"Int J Gynecol Cancer"},{"key":"2090_CR13","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","volume":"106","author":"DS Chi","year":"2006","unstructured":"Chi DS, McCaughty K, Diaz JP et al (2006) Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma. Cancer 106:1933\u20131939","journal-title":"Cancer"},{"key":"2090_CR14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","volume":"114","author":"DS Chi","year":"2009","unstructured":"Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rustum NR, Levine DA, Guile MW, Bristow RE, Aghajanian C, Barakat RR (2009) Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm. Gynecol Oncol 114:26\u201331","journal-title":"Gynecol Oncol"},{"key":"2090_CR15","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/cncr.24149","volume":"115","author":"A Bois Du","year":"2009","unstructured":"Du Bois A, Reuss A, Pujade-Lauraine E, Harter P, Ray-Coquard I, Pfisterer J (2009) Role of surgical outcome as prognostic factor in advanced epithelial ovarian cancer: a combined exploratory analysis of 3 prospectively randomized phase 3 multicenter trials: by the Arbeitsgemeinschaft Gynaekologische Onkologie Studiengruppe Ovarialkarzinom (AGO-OVAR) and the Groupe d\u2019Investigateurs Nationaux Pour les Etudes des Cancers de l\u2019Ovaire (GINECO). Cancer 115:1234\u20131244","journal-title":"Cancer"},{"issue":"3","key":"2090_CR16","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","volume":"103","author":"EL Eisenhauer","year":"2006","unstructured":"Eisenhauer EL, Abu-Rustum NR, Sonoda Y, Levine DA, Poynor EA, Aghajanian C, Jarnagin WR, DeMatteo RP, D\u2019Angelica MI, Barakat RR, Chi DS (2006) The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC\u2013IV epithelial ovarian cancer. Gynecol Oncol 103(3):1083\u20131090","journal-title":"Gynecol Oncol"},{"key":"2090_CR17","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2005.08.036","volume":"100","author":"SM Eisenkop","year":"2006","unstructured":"Eisenkop SM, Spirtos NM, Lin WC (2006) Splenectomy in the context of primary cytoreductive operations for advanced epithelial cancer. Gynecol Oncol 100:344\u2013348","journal-title":"Gynecol Oncol"},{"key":"2090_CR18","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","volume":"13","author":"P Harter","year":"2006","unstructured":"Harter P, du Bois A, Hahmann M et al (2006) Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial. Ann Surg Oncol 13:1702\u20131710","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"2090_CR19","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1177\/000313480306900511","volume":"69","author":"IA Jacobs","year":"2003","unstructured":"Jacobs IA, Chang CK, Salti G (2003) Hepatic radiofrequency ablation of metastatic ovarian granulosa cell tumors. Am Surg 69(5):416\u2013418","journal-title":"Am Surg"},{"key":"2090_CR20","first-page":"283","volume":"4","author":"GP Kanas","year":"2012","unstructured":"Kanas GP, Taylor A, Primrose JN et al (2012) Survival after liver resection in metastatic colorectal cancer: review and metaanalysis of prognostic factors. Clin Epidemiol 4:283\u2013301","journal-title":"Clin Epidemiol"},{"key":"2090_CR21","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0140-6736(14)62223-6","volume":"386","author":"S Kehoe","year":"2015","unstructured":"Kehoe S, Hook J, Nankivell M et al (2015) Primary chemotherapy versus primary surgery for newly diagnosed advanced ovarian cancer (CHORUS): an open-label, randomised, controlled, non-inferiority trial. Lancet 386:249\u2013257","journal-title":"Lancet"},{"issue":"1","key":"2090_CR22","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/IGC.0000000000000026","volume":"24","author":"V Kolev","year":"2014","unstructured":"Kolev V, Pereira EB, Schwartz M, Sarpel U, Roayaie S, Labow D, Momeni M, Chuang L, Dottino P, Rahaman J, Zakashansky K (2014) The role of liver resection at the time of secondary cytoreduction in patients with recurrent ovarian cancer. Int J Gynecol Cancer 24(1):70\u201374","journal-title":"Int J Gynecol Cancer"},{"key":"2090_CR23","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1097\/MLR.0b013e3181f37d5f","volume":"48","author":"PA Learn","year":"2010","unstructured":"Learn PA, Bach PR (2010) A decade of mortality reductions in major oncologic surgery: the impact of centralization and quality improvement. Med Care 48:1041\u20131049","journal-title":"Med Care"},{"key":"2090_CR24","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/00000421-198410000-00010","volume":"7","author":"YT Lee","year":"1984","unstructured":"Lee YT (1984) Breast carcinoma: pattern of recurrence and metastasis after mastectomy. Am J Clin Oncol 7:443\u2013449","journal-title":"Am J Clin Oncol"},{"issue":"1","key":"2090_CR25","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","volume":"112","author":"MC Lim","year":"2009","unstructured":"Lim MC, Kang S, Lee KS, Han SS, Park SJ, Seo SS, Park SY (2009) The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer. Gynecol Oncol 112(1):28\u201334","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2090_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1048-891x.2005.14406.x","volume":"15","author":"V Loizzi","year":"2005","unstructured":"Loizzi V, Rossi C, Cormio G, Cazzolla A, Altomare D, Selvaggi L (2005) Clinical features of hepatic metastasis in patients with ovarian cancer. Int J Gynecol Cancer 15(1):26\u201331","journal-title":"Int J Gynecol Cancer"},{"key":"2090_CR27","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","volume":"102","author":"PM Magtibay","year":"2006","unstructured":"Magtibay PM, Adams PB, Silverman MB, Cha SS, Podratz KC (2006) Splenectomy as part of cytoreductive surgery in ovarian cancer. Gynecol Oncol 102:369\u2013374","journal-title":"Gynecol Oncol"},{"issue":"1","key":"2090_CR28","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.ygyno.2004.12.038","volume":"97","author":"R Mateo","year":"2005","unstructured":"Mateo R, Singh G, Jabbour N, Palmer S, Genyk Y, Roman L (2005) Optimal cytoreduction after combined resection and radiofrequency ablation of hepatic metastases from recurrent malignant ovarian tumors. Gynecol Oncol 97(1):266\u2013270","journal-title":"Gynecol Oncol"},{"key":"2090_CR29","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-8258(03)00004-0","volume":"89","author":"MA Meredith","year":"2003","unstructured":"Meredith MA, Cliby WA, Keeney GL, Lesnick TG, Nagorney DM, Podratz KC (2003) Hepatic resection for metachronous metastases from ovarian carcinoma. Gynecol Oncol 89:16\u201321","journal-title":"Gynecol Oncol"},{"key":"2090_CR30","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jamcollsurg.2009.01.007","volume":"208","author":"H Nathan","year":"2009","unstructured":"Nathan H, Cameron JL, Choti MA et al (2009) The volume-outcomes effect in hepato-pancreato-biliary surgery: hospital versus surgeon contribution and specificity of the relationship. J Am Coll Surg 208:528\u2013538","journal-title":"J Am Coll Surg"},{"issue":"10","key":"2090_CR31","first-page":"4517","volume":"32","author":"UP Neumann","year":"2012","unstructured":"Neumann UP, Fotopoulou C, Schmeding M, Thelen A, Papanikolaou G, Braicu EI, Neuhaus P, Sehouli J (2012) Clinical outcome of patients with advanced ovarian cancer after resection of liver metastases. Anticancer Res 32(10):4517\u20134521","journal-title":"Anticancer Res"},{"key":"2090_CR32","first-page":"182","volume":"9","author":"G Niu","year":"2012","unstructured":"Niu G, Shen C, Cui W, Li Q (2012) Hepatic resection is safe for metachronous hepatic metastases from ovarian cancer. Cancer Biol Med 9:182\u2013187","journal-title":"Cancer Biol Med"},{"key":"2090_CR33","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00404-013-2715-1","volume":"287","author":"A Papadia","year":"2013","unstructured":"Papadia A, Morotti M (2013) Diaphragmatic surgery during cytoreduction for primary or recurrent epithelial ovarian cancer: a review of the literature. Arch Gynecol Obstet 287:733\u2013741","journal-title":"Arch Gynecol Obstet"},{"key":"2090_CR34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.gynor.2011.09.006","volume":"1","author":"A Papadia","year":"2011","unstructured":"Papadia A, Moya Y, Rodgers SE et al (2011) Surgical resection of recurrent upper abdominal cervical cancer: a case report and review of the literature. Gynecol Oncol Case Rep 1:8\u20139","journal-title":"Gynecol Oncol Case Rep"},{"issue":"2","key":"2090_CR35","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1015-9584(10)60014-0","volume":"30","author":"S Pekmezci","year":"2010","unstructured":"Pekmezci S, Saribeyoglu K, Aytac E, Arvas M, Demirkiran F, Ozguroglu M (2010) Surgery for isolated liver metastasis of ovarian cancer. Asian J Surg 30(2):83\u201388","journal-title":"Asian J Surg"},{"key":"2090_CR36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/rcs.360","volume":"7","author":"M Peterhans","year":"2011","unstructured":"Peterhans M, vom Berg A A, Dagon B et al (2011) A navigation system for open liver surgery: design, workflow and first clinical applications. Int J Med Robot 7:7\u201316","journal-title":"Int J Med Robot"},{"key":"2090_CR37","doi-asserted-by":"crossref","unstructured":"Prat J (2015) FIGO Committee on Gynecologic Oncology. Abridged republication of FIGO\u2019s staging classification for cancer of the ovary, fallopian tube, and peritoneum. Cancer. doi: 10.1002\/cncr.29524","DOI":"10.1002\/cncr.29524"},{"issue":"5","key":"2090_CR38","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00404-010-1750-4","volume":"284","author":"HJ Roh","year":"2011","unstructured":"Roh HJ, Kim DY, Joo WD, Yoo HJ, Kim JH, Kim YM, Kim YT, Nam JH (2011) Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver. Arch Gynecol Obstet 284(5):1223\u20131229","journal-title":"Arch Gynecol Obstet"},{"key":"2090_CR39","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1002\/1097-0142(19891001)64:7<1508::AID-CNCR2820640725>3.0.CO;2-V","volume":"64","author":"PG Rose","year":"1989","unstructured":"Rose PG, Piver MS, Tsukada Y, Lau TS (1989) Metastatic patterns in histologic variants of ovarian cancer. An autopsy study. Cancer 64:1508\u20131513","journal-title":"Cancer"},{"key":"2090_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","volume":"62","author":"R Siegel","year":"2012","unstructured":"Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62:10\u201329","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"2090_CR41","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/j.1048-891x.2004.14326.x","volume":"14","author":"S Tangjitgamol","year":"2004","unstructured":"Tangjitgamol S, Levenback CF, Beller U, Kavanagh JJ (2004) Role of surgical resection for lung, liver, and central nervous system metastases in patients with gynecological cancer: a literature review. Int J Gynecol Cancer 14(3):399\u2013422","journal-title":"Int J Gynecol Cancer"},{"key":"2090_CR42","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.critrevonc.2014.12.004","volume":"94","author":"G Veereman","year":"2015","unstructured":"Veereman G, Robays J, Verleye L et al (2015) Pooled analysis of the surgical treatment for colorectal cancer liver metastases. Crit Rev Oncol\/Hematol 94:122\u2013135","journal-title":"Crit Rev Oncol\/Hematol"},{"key":"2090_CR43","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","volume":"363","author":"I Vergote","year":"2010","unstructured":"Vergote I, Trop\u00e9 CG, Amant FA et al (2010) Neoadjuvant chemotherapy or primary surgery in stage IIIc\u2013IV ovarian cancer. N Engl J Med 363:943\u2013953","journal-title":"N Engl J Med"},{"key":"2090_CR44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.sla.0000150244.72285.ad","volume":"241","author":"J Weitz","year":"2005","unstructured":"Weitz J, Blumgart LH, Fong Y, Jarnagin WR, D\u2019Angelica M, Harrison LE et al (2005) Partial hepatectomy for metastases from noncolorectal, nonneuroendocrine carcinoma. Ann Surg 241:269\u2013276","journal-title":"Ann Surg"},{"key":"2090_CR45","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","volume":"26","author":"WE Winter III","year":"2008","unstructured":"Winter WE III, Maxwell GL, Tian C, Sundborg MJ, Rose GS, Rose PG et al (2008) Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study. J Clin Oncol 26:83\u201389","journal-title":"J Clin Oncol"},{"issue":"2","key":"2090_CR46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.ygyno.2003.07.005","volume":"91","author":"SS Yoon","year":"2003","unstructured":"Yoon SS, Jarnagin WR, Fong Y, DeMatteo RP, Barakat RR, Blumgart LH, Chi DS (2003) Resection of recurrent ovarian or fallopian tube carcinoma involving the liver. Gynecol Oncol 91(2):383\u2013388","journal-title":"Gynecol Oncol"},{"key":"2090_CR47","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1038\/bjc.2011.328","volume":"105","author":"RY Zang","year":"2011","unstructured":"Zang RY, Harter P, Chi DS et al (2011) Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort. Br J Cancer 105:890\u2013896","journal-title":"Br J Cancer"}],"container-title":["Journal of Cancer Research and Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-2090-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00432-015-2090-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00432-015-2090-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T03:54:18Z","timestamp":1692158058000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00432-015-2090-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12,11]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["2090"],"URL":"https:\/\/doi.org\/10.1007\/s00432-015-2090-3","relation":{},"ISSN":["0171-5216","1432-1335"],"issn-type":[{"value":"0171-5216","type":"print"},{"value":"1432-1335","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,12,11]]}}}